IgE and D-dimer baseline levels are higher in responders than nonresponders to omalizumab in chronic spontaneous urticaria.
Massimo CugnoGiovanni GenoveseS FerrucciG CasazzaR AseroA V MarzanoPublished in: The British journal of dermatology (2018)
Keyphrases